{"id":"W4242642633","doi":"10.1093/annonc/mdw525.48","title":"KEYNOTE-122: Phase 2 study of pembrolizumab versus standard-of-care chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal carcinoma","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Docetaxel; Regimen; Internal medicine; Oncology; Gemcitabine; Capecitabine; Phases of clinical research; Chemotherapy; Chemotherapy regimen; Response Evaluation Criteria in Solid Tumors; Cancer; Immunotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001474759,0.001520445,0.002327438,0.0004401739,0.0004502154,0.001338406,0.001314571,0.001451671,0.008214198],"category_scores_gemma":[0.001226377,0.0006976673,0.001577765,0.0004058432,0.0008201853,0.001357486,0.0003624536,0.003912902,0.00151364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001058382,"about_ca_system_score_gemma":0.001409813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001734307,"about_ca_topic_score_gemma":0.0044197,"domain_scores_codex":[0.9996498,0.000164174,0.00001726932,0.00006225165,0.00003155789,0.0000749551],"domain_scores_gemma":[0.999453,0.0001007749,0.00009024896,0.00005027079,0.00004075395,0.0002649642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8336065,0.05374177,0.001869236,0.001486142,0.001732091,0.0001391864,0.000199808,0.002029744,0.02416069,0.0004122617,0.005170826,0.07545177],"study_design_scores_gemma":[0.7889023,0.2023429,0.003385064,0.00004208573,0.0005124054,0.0001184359,0.00005378347,0.0007489322,0.001858059,0.00016444,0.001846307,0.00002536808],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860427,0.002862861,0.0005683858,0.0007399163,0.0004306343,0.003081207,0.002119129,0.0001581831,0.003996874],"genre_scores_gemma":[0.9807513,0.003216363,0.002051569,0.001368736,0.0003839259,0.003262609,0.002699908,0.00005923652,0.006206295],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008214198,"threshold_uncertainty_score":0.02747923,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1372652951794882,"score_gpt":0.4518815340261645,"score_spread":0.3146162388466763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}